Modelling the potential impact of abuse-deterrent opioids on medical resource utilization.
Conclusion: Agonist/antagonist abuse-deterrent opioid technology is associated with higher annual medical cost savings and more avoided events than physical/chemical barrier technology. Total net savings are dependent upon the abuse-deterrent opioid price relative to non-abuse-deterrent opioids.
PMID: 31314616 [PubMed - as supplied by publisher]
Source: Journal of Medical Economics - Category: Health Management Tags: J Med Econ Source Type: research
More News: Chemistry | Economics | Emergency Medicine | Fentanyl | Health Management | Men | Morphine | Oxycodone | OxyContin | Study | Substance Abuse | USA Health